Cupid lifts FY27 revenue target by 10% on condoms, IVD and personal care push
Cupid Ltd raised its FY27 revenue outlook by at least 10%, guiding to ₹150 crore in Q1 FY27. Growth is driven by its condom and IVD segments, a new mainstream personal care brand, and rising international B2B healthcare demand.
What happened
Cupid Ltd, an Indian consumer wellness and personal care company, raised its FY27 revenue outlook by at least 10%, citing growth in condoms, IVD, and a
Key facts
- ₹150 crore Q1 FY27 revenue
- 10% upward revision FY27
Why this matters
The new mainstream personal care brand and rising international B2B healthcare demand widen Cupid's addressable market and could open partnership, co-manufacturing, or distribution-alliance opportunities beyond its core contraceptive base.
What to watch
- Quarterly revenue beat/miss vs ₹150cr Q1 marker
- Gross and EBITDA margin trend amid new-brand spend
- IVD segment pricing/competitive intensity
- FX moves and export demand from healthcare B2B clients
- Any management commentary revising or reaffirming FY27 target
- Track Q1 FY27 actuals against the ₹150cr guidepost for early credibility signal
- Scrutinize segment mix disclosure (condom vs IVD vs personal care vs B2B exports)
- Watch for distribution/marketing spend tied to the mainstream personal care launch
- Monitor international B2B order book and receivables for export-led growth quality